Low-dose CT screening for lung cancer does not result in diminished health quality of life or long term anxiety, study says.
Lung cancer screening with low-dose CT (LDCT) may cause some short–term psychological discomfort in patients, but is not associated with long-term distress, according to an article published in the Journal of Thoracic Oncology (JTO).
Researchers from the Department of Veterans Affairs Hospital in Portland, Ore., undertook a study to determine the effects of LDCT lung cancer screening and patient-centered outcomes. This screening is now widely recommended for people at high risk of developing lung cancer – current and former heavy smokers.
The researchers searched for randomized controlled trials or large cohort studies that screened asymptomatic adults who were at high risk for lung cancer. Out of 8,215 abstracts, the researchers found six publications that reported on patient-centered outcomes. Five were from two European randomized controlled trials and one from a cohort study in the United States.
The findings from these publications indicated that while LDCT lung cancer screening could cause short-term anxiety or discomfort, the screening was not associated with health-related quality of life. Distress caused by false-positive results did increase in the short-term, but decreased over time to similar levels of those who had received negative results.
"Given that false positive results can never be entirely eliminated from LDCT screening and the suggestion that there is some short-term distress associated with a positive result, careful consideration of eligibility criteria, optimization of diagnostic algorithms, and thorough discussions of risks, benefits, values, preferences, results, implications of results, and follow-up plans with patients may improve patient-centered outcomes,” lead author Christopher Slatore, MD, MS, said in a release.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
AI Adjudication Bolsters Chest CT Assessment of Lung Adenocarcinoma
April 11th 2024The inclusion of simulated adjudication for resolving discordant nodule classifications in a deep learning model for assessing lung adenocarcinoma on chest CT resulted in a 12 percent increase in sensitivity rate.